Lindsay Gellman is a journalist who writes about business, technology, health, and culture.
Her work has been featured in The Wall Street Journal, where she was a staff reporter for several years, as well as The New York Times, The New Yorker, The Atlantic, New York Magazine, Bloomberg Businessweek, WIRED, National Geographic, Los Angeles Review of Books, British Vogue, and on National Public Radio’s All Things Considered.
She has contributed investigative research to bestselling journalistic book projects, including Ronan Farrow’s Catch and Kill and Brad Stone’s Amazon Unbound, and to development work for documentary films.
Her investigative reporting on unscrupulous medical businesses has been supported by the National Institute for Health Care Management Foundation and the Knight Science Journalism Fellowship at Massachusetts Institute of Technology. She was also a visiting scholar at the New York University Langone Division of Medical Ethics.
Lindsay spent a year in Berlin as a Fulbright fellow covering technology startups and the arts. While in Germany, she also reported on exploitative cancer clinics. Her reporting was published in German and English, and triggered a law-enforcement investigation and changes to crowdfunding-platform policies.
Lindsay earned a B.A. with distinction in the English major from Yale College, where she focused on the literature of the American South and completed the Writing Concentration in fiction. Her essay “The Moral Meaning of a Pause” won a Yale Writing Center prize in 2009, and was anthologized in the composition textbook Fields of Reading: Motives for Writing, 10th Ed., Bedford/St. Martin’s (2012). She was a staff writer for The Yale Daily News, covering the sciences.
-A Hamptons Property Fight Over a Black Whaler’s Homestead (The New York Times)
-The Girlbosses of Fertility (New York Magazine’s The Cut)
-Dubious Alternative Lyme Treatments are Killing Patients (Bloomberg Businessweek)
-Fighting the Shame of Skin Picking (The New York Times)
-Save Our Starbucks (The New Yorker)
-The ‘Cadillac of Mailboxes’ Arrives in N.Y.C. (The New Yorker)
-Ida Tin’s Battle to Build Clue, a Period-Tracking App (The New Yorker)
-The Last Resort: Private clinics in Germany sell cancer patients hope — and mixed results — at exorbitant prices. Some, like the Hallwang Clinic, cater primarily to foreigners. (Longreads)